Page last updated: 2024-09-02

ramosetron and Uterine Neoplasms

ramosetron has been researched along with Uterine Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Nakayama, S; Noda, T; Torii, Y	1

Trials

1 trial(s) available for ramosetron and Uterine Neoplasms

Article	Year
[Evaluation of efficacy of ramosetron orally disintegrating tablets and patient preference as to the dosage form in gynecological cancer chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2001, Volume: 28, Issue:8 Topics: Administration, Oral; Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Endometrial Neoplasms; Female; Granisetron; Humans; Middle Aged; Nausea; Ovarian Neoplasms; Serotonin Antagonists; Uterine Cervical Neoplasms; Uterine Neoplasms; Vomiting, Anticipatory	2001

Article

Year

[Evaluation of efficacy of ramosetron orally disintegrating tablets and patient preference as to the dosage form in gynecological cancer chemotherapy].

Gan to kagaku ryoho. Cancer & chemotherapy, 2001, Volume: 28, Issue:8

Topics: Administration, Oral; Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Endometrial Neoplasms; Female; Granisetron; Humans; Middle Aged; Nausea; Ovarian Neoplasms; Serotonin Antagonists; Uterine Cervical Neoplasms; Uterine Neoplasms; Vomiting, Anticipatory

2001